Skip to main content
. 2018 Dec 14;19(1):27–46. doi: 10.1007/s40268-018-0256-6

Fig. 1.

Fig. 1

Composition of patients. *16 patients in the ‘Initial dose did not follow approved dose’ and ‘Overall global improvement (assessed by physician and patient) and clinical effects unevaluable’ categories overlapped